Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud

• Autores: Huaman Sanchez, Karen, Huaroto, Fabiola, Bonilla, Catherine, Aramburú, Adolfo, Morales Barrenechea, Javier, Gutiérrez, Ericson L., Curisinche, Maricela, Rojas Bolivar, Daniel, Gonzales Zurita, Diana Maria, Sánchez Ramírez, Jose Carlos, Reyes Puma, Nora
• Formato: artículo
• Fecha de Publicación: 2022
• Institución: Universidad de Lima
• Repositorio: ULIMA-Institucional
• Lenguaje: español
• OAI Identifier: oai:repositorio.ulima.edu.pe:20.500.12724/18132
• Enlace del recurso: https://hdl.handle.net/20.500.12724/18132; https://doi.org/10.35434/rcmhnaaa.2022.15Supl.%201.1542
• Nivel de acceso: acceso abierto
• Materia: Pendiente; https://purl.org/pe-repo/ocde/ford#5.01.00

The COVID-19 pandemics required the countries to take decisions rapidly. Consequently, the National Institute of Health (INS) developed a series of documents of scientific evidence synthesis according to the Ministry of Health’s requirements. Based on these reports, the INS developed recommendations to update normative documents related to COVID-19’s management. This article describes the construction of anew methodology applied by the INS to synthesize scientific evidence during the COVID-19 pandemic. Moreover, it emphasizes the efforts and strategies used to guarantee the methodological quality and the implementation of the GRADE approach. Finally, it provides a short reflection on the limitations and challenges of using evidence to design national public policies in the future.